Prism Medico and Pharmacy Allots 75,00,000 Equity Shares and 50,00,000 Convertible Warrants on Preferential Basis

Prism Medico & Pharmacy Limited held a Board of Directors meeting on May 05, 2026, at its registered office located at Suketi Road, Kala Amb, Sirmaur, Himachal Pradesh. The board approved the allotment of equity shares and convertible warrants on a preferential basis, a development rooted in shareholder approval obtained at an earlier Extra-ordinary General Meeting.

Preferential Allotment Details

The board approved the allotment of 75,00,000 (Seventy Five Lacs) equity shares and 50,00,000 (Fifty Lacs) convertible warrants. Both the equity shares and the convertible warrants carry a face value of ₹10/- each and were issued at an issue price of ₹10/- per unit. The following table summarises the key parameters of the allotment:

Parameter: Details Equity Shares Allotted: 75,00,000 (Seventy Five Lacs) Face Value per Equity Share: ₹10/- Issue Price per Equity Share: ₹10/- Convertible Warrants Allotted: 50,00,000 (Fifty Lacs) Issue Price per Warrant: ₹10/- Allotment Basis: Preferential Basis Board Meeting Date: May 05, 2026 Meeting Commencement: 11.00 am Meeting Conclusion: 4.00 pm

Regulatory and Shareholder Approvals

The allotment was carried out in accordance with and pursuant to a special resolution passed by the members of the company at their Extra-ordinary General Meeting held on March 20, 2026. Additionally, In-Principle Approval was received from BSE Ltd, the stock exchange where the shares of the company are listed, on March 25, 2026. The details of the allottees have been enclosed with the exchange communication.

Board Authorisation

The outcome of the board meeting was communicated to the exchanges by Director Davender Singh (DIN: 09447213). The disclosure was made to both BSE Limited and the Metropolitan Stock Exchange of India Limited (MSEI) as part of the company's regulatory obligations under Regulation 30.

Prism medico & pharmacy Limited has filed its quarterly compliance certificate with BSE Limited and Metropolitan Stock Exchange of India Limited (MSEI) for the quarter ended March 31, 2026. The submission fulfills regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018.

Regulatory Compliance Submission

The company submitted the confirmation certificate as mandated by Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. The certificate was issued by Purva Sharegistry (India) Pvt. Ltd., which serves as the company's Registrar and Share Transfer Agent (RTA).

Parameter: Details Quarter Ended: March 31, 2026 Regulation: SEBI Regulation 74(5) RTA: Purva Sharegistry (India) Pvt. Ltd. Submission Date: April 13, 2026

Share Dematerialization Activity

The detailed report covering the period from January 1, 2026 to March 31, 2026 shows no dematerialization activity during the quarter. The certificate confirms that no security certificates were received from depository participants for dematerialization during this period.

Activity Type: Status Share Certificates Dematerialized: NIL Folio Numbers: NIL Certificate Numbers: NIL Total Shares: NIL

RTA Confirmation

Purva Sharegistry (India) Pvt. Ltd., a SEBI registered Category 1 Registrar and Share Transfer Agent, confirmed compliance with all regulatory requirements. The RTA verified that securities received for dematerialization are processed within prescribed timelines and that proper procedures are followed for certificate handling and member register updates.

Company Information

Prism Medico and Pharmacy Limited is registered in Himachal Pradesh with its office located at Suketi Road, Kala Amb, Sirmaur. The company's shares are listed on both BSE Limited and Metropolitan Stock Exchange of India Limited. Director Davender Singh signed the compliance submission on behalf of the company.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.